Quasar targets the medical market for strategic focus

Quasar targets the medical market for strategic focus

The market for medical devices is growing rapidly, with minimally invasive devices increasingly important and requiring highly skilled manual assembly of numerous components. This specialized assembly and production necessitates a trusted manufacturing partner.

Quasar has taken the strategic decision to focus its manufacturing expertise solely on products for the medical market, such as devices, catheters and disposables.

With 30 years of manufacturing experience, Quasar offers its customers the combination of Israeli innovation and Far Eastern advantages. Bringing a host of benefits to its partnerships, including cGMP compliance, micro assembly capabilities, cleanroom manufacturing (ISO Class 6-8), design and execution of accurate production tools and jigs in order to consistently manufacture at superior standards.

As a customer-centric manufacturing company, Quasar operates in full partnership with its customers through the entire manufacturing process. From preliminary engineering support to product design, NPI and onwards to mass production.  Quasar focuses on customer success, ensuring that the final results will be both cost-effective and of the highest quality possible.

Read More

EU MDR 2020: What to Expect

The EU MDR allowed a 3-year transition period for medical device manufacturers to comply. This runway ends in May 2020, where after the EU MDR comes into full effect. After this point, every part of the medical device supply chain from manufacturers to importers and distributors in the EU, will be required to comply.

Read more...